ROYCE & ASSOCIATES LP - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 1 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 5.9%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$3,000
-99.9%
2,886
-99.3%
0.00%
-100.0%
Q1 2015$3,466,000388,6000.01%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TRV GP, LLC 4,841,591$5,084,0003.60%
SABBY MANAGEMENT, LLC 2,452,234$2,574,0000.15%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,205,925$1,266,0000.10%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,593,626$1,673,0000.03%
AJ WEALTH STRATEGIES, LLC 39,665$42,0000.01%
Virtu Financial LLC 45,804$48,0000.00%
DRW Securities, LLC 40,000$42,0000.00%
SIMPLEX TRADING, LLC 34,429$36,0000.00%
Squarepoint Ops LLC 38,277$40,0000.00%
FIDUCIARY TRUST CO 20,000$21,0000.00%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders